Active, Not Recruiting
Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)
NCT04944979
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
- Locations
-
- Benioff Children's Hospital - Mission Bay San Francisco, California, United States
- IMMUNOe Health and Research Centers Centennial, Colorado, United States
- Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
- Velocity Clinical Research - MedPharmics - Lafayette Lafayette, Louisiana, United States